EPISODE · Dec 1, 2017 · 6 MIN
The True Costs of the 21-Gene Assay in a Cohort of 1,000 Patients
from Journal of Clinical Oncology (JCO) Podcast · host Jennifer J. Griggs
This podcast addresses the clinical implications of the high cost of the 21-gene assay in women with ER-positive, node-negative breast cancer. Related Article: Population-Based Study to Determine the Health System Costs of Using the 21-Gene Assay
Embed this episode
Ready to play
The True Costs of the 21-Gene Assay in a Cohort of 1,000 Patients
0:00
6:41
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Journal of Clinical Oncology (JCO) Podcast?
This episode is 6 minutes long.
When was this Journal of Clinical Oncology (JCO) Podcast episode published?
This episode was published on December 1, 2017.
Can I download this Journal of Clinical Oncology (JCO) Podcast episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!